NCPA


Policy Issues

NCPA Publications

Both Sides

Editorial Opinions

Audio/Visual


NATIONAL CENTER FOR POLICY ANALYSIS
HOME / DONATE / ONE LEVEL UP / ABOUT NCPA / CONTACT US
Illegal Drug Reimportation Plagues European Countries
Daily Policy Digest

Health Issues / Drug Reimportation and Price Controls

Tuesday, October 15, 2002
The pharmaceutical industry's program of sending HIV/AIDS drugs to Africa at preferential prices has been undermined by reimportation of the cheap drugs to Europe to sell at full price. Several pharmaceutical companies provide essential medicines at prices near the cost of production to poor countries under the accelerating access initiative. However, some of their products have been found in store shelves in Europe.

  • An investigation by Belgian customs authorities found that at least three million doses of the drug Combivir -- earmarked for sale in Africa at about $0.78 per dose -- have found their way onto European pharmacists' shelves, where they sell for about $5.94 per dose.
  • An estimated 28 shipments of GlaxoSmithKline's antiretroviral drugs, Epivir and Trizivir -- with a retail value $28 million -- came back to Antwerp through Paris and Brussels.
  • GlaxoSmithKline estimated that about a quarter of the drugs it had exported to Africa had come back to Europe.
Many of the drugs were supposed to go to HIV/AIDS clinics in Senegal, the Ivory Coast, the Republic of Congo, Togo and Guinea-Bissau. The Dutch government has issued a recall of all batches of Combivir originally intended for use in Africa. At the very least, European laws against the re-importation of exported European goods were infringed.

Source: Owen Dyer, "Cost Price Drugs for Developing Countries are Found in Belgian Pharmacies," British Medical Journal, October 12, 2002.

For text
http://bmj.com/cgi/content/full/325/7368/794

For more on Drug Reimportation and Price Controls
http://www.ncpa.org/iss/hea
12770 Coit Rd., Suite 800 - Dallas, TX 75251-1339 - 972/386-6272 - Fax 972/386-0924
601 Pennsylvania Ave. NW, Suite 900 South Building - Washington, DC 20004 - 202/220-3082 - Fax 202/220-3096
Copyright © 2002 National Center for Policy Analysis - All rights reserved.